RVTY

NYSE Revvity, Inc.

Oct 24, 2026 · 4:16 AM ET EOD Market Closed

$158.77 ↑ +0.00 (+0.00%) Trading Up from the previous close of $158.77, $0.28 below the day’s high of $159.05

YTD change: +64.10%
vs 20-day SMA: +3.43%
vs 200-day SMA: +44.06%

Price ranges

Previous day

$152.73 $159.05

open $156.35 close $158.77

+$2.42 (+1.55%)

Today

$152.73 $159.05

$158.77

Past week

$150.71 $161.64

from $154.71 now $158.77

+$4.06 (+2.62%)

Past month

$146.70 $166.25

from $150.68 now $158.77

+$8.09 (+5.37%)

This year

$81.22 $166.25

from $96.75 now $158.77

+$62.02 (+64.10%)

Price & Performance

+72.00 (+82.98%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good

The stock is 4.5% away from all-time highs of $166.25
RVTY is up 64% since the beginning of the year
RVTY is up 63% over the past 12 months
RVTY is up 5% over the past 1 month
6% of all RVTY investors are betting against RVTY
Number of investors short RVTY has gone down 0% versus last month

RVTY reads very good: price sits above both the 20- and 200-day averages, short interest is falling month over month, the 12-month move is +60.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes

EPS $1.41

Earnings momentum -8.8% Quarterly EPS growth

Quarterly change -8.8%

Valuation

P/E ratio 74.93

Enterprise value $19.9B

Beta 1.09

Balance sheet & scale

Income$237.4K

Revenue$2.9B

Cash$1.0B

Debt$3.3M

Income / Debt 0.07×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE

Sector Manufacturing

Sub Sector Computer and Electronic Product Manufacturing

Market cap $17.7B

Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. The firm operates through the following segments: Life Sciences and Diagnostics. The Life Sciences segment delivers innovative solutions to optimize workflows, boost productivity, and accelerate drug discovery and development. The Diagnostics segment provides instruments, reagents, assay platforms, and software to healthcare and research professionals, with a focus on reproductive health, immunodiagnostics, emerging market diagnostics, and applied genomics to enhance patient outcomes. Revvity was founded on April 19, 1937 and is headquartered in Waltham, MA.

Competitor comparison

Ticker	Company	Price	Change
A	Agilent Technologies, Inc.	$173.07	-0.47%
WAT	Waters Corporation	$453.67	-0.42%
ILMN	Illumina, Inc.	$269.42	+0.01%
MTD	Mettler-Toledo International Inc.	$1,670.29	-0.85%
SOAGY	Sartorius AG Unsponsored ADR Pfd	$63.26	+2.64%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.